RATIONALE: Fatty acid nitroalkenes are endogenously generated electrophilic byproducts of nitric oxide and nitrite-dependent oxidative inflammatory reactions. Existing evidence indicates nitroalkenes support posttranslational protein modifications and transcriptional activation that promote the resolution of inflammation. OBJECTIVE: The aim of this study was to assess whether in vivo administration of a synthetic nitroalkene could elicit antiinflammatory actions in vivo using a murine model of vascular injury. METHODS AND RESULTS: The in vivo administration (21 days) of nitro-oleic acid (OA-NO(2)) inhibited neointimal hyperplasia after wire injury of the femoral artery in a murine model (OA-NO(2) treatment resulted in reduced intimal area and intima to media ratio versus vehicle- or oleic acid (OA)-treated animals,P<0.0001). Increased heme oxygenase (HO)-1 expression accounted for much of the vascular protection induced by OA-NO(2) in both cultured aortic smooth muscle cells and in vivo. Inhibition of HO by Sn(IV)-protoporphyrin or HO-1 small interfering RNA reversed OA-NO(2)-induced inhibition of platelet-derived growth factor-stimulated rat aortic smooth muscle cell migration. The upregulation of HO-1 expression also accounted for the antistenotic actions of OA-NO(2) in vivo, because inhibition of neointimal hyperplasia following femoral artery injury was abolished in HO-1(-/-) mice (OA-NO(2)-treated wild-type versus HO-1(-/-) mice, P=0.016). CONCLUSIONS: In summary, electrophilic nitro-fatty acids induce salutary gene expression and cell functional responses that are manifested by a clinically significant outcome, inhibition of neointimal hyperplasia induced by arterial injury.
RATIONALE: Fatty acidnitroalkenes are endogenously generated electrophilic byproducts of nitric oxide and nitrite-dependent oxidative inflammatory reactions. Existing evidence indicates nitroalkenes support posttranslational protein modifications and transcriptional activation that promote the resolution of inflammation. OBJECTIVE: The aim of this study was to assess whether in vivo administration of a synthetic nitroalkene could elicit antiinflammatory actions in vivo using a murine model of vascular injury. METHODS AND RESULTS: The in vivo administration (21 days) of nitro-oleic acid (OA-NO(2)) inhibited neointimal hyperplasia after wire injury of the femoral artery in a murine model (OA-NO(2) treatment resulted in reduced intimal area and intima to media ratio versus vehicle- or oleic acid (OA)-treated animals,P<0.0001). Increased heme oxygenase (HO)-1 expression accounted for much of the vascular protection induced by OA-NO(2) in both cultured aortic smooth muscle cells and in vivo. Inhibition of HO by Sn(IV)-protoporphyrin or HO-1 small interfering RNA reversed OA-NO(2)-induced inhibition of platelet-derived growth factor-stimulated rat aortic smooth muscle cell migration. The upregulation of HO-1 expression also accounted for the antistenotic actions of OA-NO(2) in vivo, because inhibition of neointimal hyperplasia following femoral artery injury was abolished in HO-1(-/-) mice (OA-NO(2)-treated wild-type versus HO-1(-/-) mice, P=0.016). CONCLUSIONS: In summary, electrophilic nitro-fatty acids induce salutary gene expression and cell functional responses that are manifested by a clinically significant outcome, inhibition of neointimal hyperplasia induced by arterial injury.
Authors: D A Tulis; A N Keswani; K J Peyton; H Wang; A I Schafer; W Durante Journal: Cell Mol Biol (Noisy-le-grand) Date: 2005-10-03 Impact factor: 1.770
Authors: V B O'Donnell; K B Taylor; S Parthasarathy; H Kühn; D Koesling; A Friebe; A Bloodsworth; V M Darley-Usmar; B A Freeman Journal: J Biol Chem Date: 1999-07-16 Impact factor: 5.157
Authors: Hong Pyo Kim; Xue Wang; Atsunori Nakao; Sung Il Kim; Noriko Murase; Mary E Choi; Stefan W Ryter; Augustine M K Choi Journal: Proc Natl Acad Sci U S A Date: 2005-07-28 Impact factor: 11.205
Authors: Francisco J Schopfer; Yiming Lin; Paul R S Baker; Taixing Cui; Minerva Garcia-Barrio; Jifeng Zhang; Kai Chen; Yuqing E Chen; Bruce A Freeman Journal: Proc Natl Acad Sci U S A Date: 2005-02-08 Impact factor: 11.205
Authors: Hozumi Motohashi; Fumiki Katsuoka; James Douglas Engel; Masayuki Yamamoto Journal: Proc Natl Acad Sci U S A Date: 2004-04-15 Impact factor: 11.205
Authors: Albena T Dinkova-Kostova; W David Holtzclaw; Robert N Cole; Ken Itoh; Nobunao Wakabayashi; Yasutake Katoh; Masayuki Yamamoto; Paul Talalay Journal: Proc Natl Acad Sci U S A Date: 2002-08-22 Impact factor: 11.205
Authors: Antonio D'Amore; Marco Fazzari; Hong-Bin Jiang; Samuel K Luketich; Michael E Luketich; Richard Hoff; Daniel L Jacobs; Xinzhu Gu; Stephen F Badylak; Bruce A Freeman; William R Wagner Journal: Tissue Eng Part A Date: 2018-02-27 Impact factor: 3.845
Authors: Darcy J P Bates; Pamela K Smitherman; Alan J Townsend; S Bruce King; Charles S Morrow Journal: Biochemistry Date: 2011-08-17 Impact factor: 3.162
Authors: Carl D Koch; Mark T Gladwin; Bruce A Freeman; Jon O Lundberg; Eddie Weitzberg; Alison Morris Journal: Free Radic Biol Med Date: 2016-12-16 Impact factor: 7.376
Authors: Imad Al Ghouleh; Nicholas K H Khoo; Ulla G Knaus; Kathy K Griendling; Rhian M Touyz; Victor J Thannickal; Aaron Barchowsky; William M Nauseef; Eric E Kelley; Phillip M Bauer; Victor Darley-Usmar; Sruti Shiva; Eugenia Cifuentes-Pagano; Bruce A Freeman; Mark T Gladwin; Patrick J Pagano Journal: Free Radic Biol Med Date: 2011-06-14 Impact factor: 7.376
Authors: Anna Klinke; Annika Möller; Michaela Pekarova; Thorben Ravekes; Kai Friedrichs; Matthias Berlin; Katrin M Scheu; Lukas Kubala; Hana Kolarova; Gabriela Ambrozova; Ralph T Schermuly; Steven R Woodcock; Bruce A Freeman; Stephan Rosenkranz; Stephan Baldus; Volker Rudolph; Tanja K Rudolph Journal: Am J Respir Cell Mol Biol Date: 2014-07 Impact factor: 6.914